甘乐能(Intron A)成为世界上第一个用于临床的干扰素。
基于40个网页-相关网页
...准上市，用于防止肾移植排斥；第一个基因重组疫苗上市(乙肝疫苗，Recombivax2HB)；第一个抗肿瘤生物技术药物α2A干扰素(Intron A)上市。
It has also improved on Rebetron with a drug called Peg-Intron, a "pegylated" combination of interferon and polyethylene glycol (Peg for short).
FORBES: The Next HIV?
In September Schering announced plans for a 2, 880-person trial to prove once and for all that Peg-Intron is a better drug.
FORBES: Magazine Article
Pegasys' only competition will be PEG-Intron, a very similar drug made by Kenilworth, N.
FORBES: Roche And Schering's Desperate Duel
应用推荐
模块上移
模块下移
不移动